Skip to main content
Top
Published in: Nuclear Medicine and Molecular Imaging 4/2014

01-12-2014 | Case Report

Brain MRI, Tc-99m HMPAO SPECT and F-18 FP-CIT PET/CT Findings in a Patient with Wilson Disease: A Case Report

Authors: Seungyoo Kim, In Uk Song, Yong An Chung, Eun Kyung Choi, Jin Kyoung Oh

Published in: Nuclear Medicine and Molecular Imaging | Issue 4/2014

Login to get access

Abstract

A 34-year-old female had experienced head and hand tremors with a dystonic component for 8 months. Brain MRI showed T2 high signal intensity in the periaqueductal region, dorsal midbrain and dorsal upper pons. No abnormal uptake was noted on Tc-99m HMPAO SPECT or F-18 FP-CIT PET/CT. Wilson disease was diagnosed according to the 2008 consensus guideline from the American Association for the Study of Liver Disease and 2012 guideline from the European Association for the Study of the Liver. This case demonstrates T2 signal change in the basal ganglia, excluding the putamen, in a Wilson disease patient with relatively severe clinical findings, but normal Tc-99m HMPAO SPECT and F-18 FP-CIT PET/CT.
Literature
1.
go back to reference Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089–111.PubMedCrossRef Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089–111.PubMedCrossRef
2.
go back to reference EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012;56:671–85. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012;56:671–85.
3.
go back to reference van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology. 1996;198:531–6.PubMedCrossRef van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology. 1996;198:531–6.PubMedCrossRef
4.
go back to reference Saatci I, Topcu M, Baltaoglu FF, Köse G, Yalaz K, Renda Y, et al. Cranial MR findings in Wilson’s disease. Acta Radiol. 1997;38:250–8.PubMedCrossRef Saatci I, Topcu M, Baltaoglu FF, Köse G, Yalaz K, Renda Y, et al. Cranial MR findings in Wilson’s disease. Acta Radiol. 1997;38:250–8.PubMedCrossRef
5.
go back to reference Schlaug G, Hefter H, Engelbrecht V, Kuwert T, Arnold S, Stöcklin G, et al. Neurological impairment and recovery in Wilson’s disease: evidence from PET and MRI. J Neurol Sci. 1996;136:129–39.PubMedCrossRef Schlaug G, Hefter H, Engelbrecht V, Kuwert T, Arnold S, Stöcklin G, et al. Neurological impairment and recovery in Wilson’s disease: evidence from PET and MRI. J Neurol Sci. 1996;136:129–39.PubMedCrossRef
6.
go back to reference Pujol A, Pujol J, Graus F, Rimola A, Peri J, Mercader JM, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology. 1993;43:65–9.PubMedCrossRef Pujol A, Pujol J, Graus F, Rimola A, Peri J, Mercader JM, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology. 1993;43:65–9.PubMedCrossRef
7.
go back to reference Jeon B, Kim JM, Jeong JM, Kim KM, Chang YS, Lee DS, et al. Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson’s disease. J Neurol Neurosurg Psychiatry. 1998;65:60–4.PubMedCentralPubMedCrossRef Jeon B, Kim JM, Jeong JM, Kim KM, Chang YS, Lee DS, et al. Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson’s disease. J Neurol Neurosurg Psychiatry. 1998;65:60–4.PubMedCentralPubMedCrossRef
8.
go back to reference Piga M, Murru A, Satta L, Serra A, Sias A, Loi G, et al. Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson’s disease. Eur J Nucl Med Mol Imaging. 2008;35:716–24.PubMedCrossRef Piga M, Murru A, Satta L, Serra A, Sias A, Loi G, et al. Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson’s disease. Eur J Nucl Med Mol Imaging. 2008;35:716–24.PubMedCrossRef
9.
go back to reference Barthel H, Hermann W, Kluge R, Hesse S, Collingridge DR, Wagner A, et al. Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. AJNR Am J Neuroradiol. 2003;24:234–8.PubMed Barthel H, Hermann W, Kluge R, Hesse S, Collingridge DR, Wagner A, et al. Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. AJNR Am J Neuroradiol. 2003;24:234–8.PubMed
10.
go back to reference Barthel H, Sorger D, Kühn HJ, Wagner A, Kluge R, Hermann W. Differential alteration of the nigrostriatal dopaminergic system in Wilson’s disease investigated with [123I]ss-CIT and high-resolution SPET. Eur J Nucl Med. 2001;28:1656–63.PubMedCrossRef Barthel H, Sorger D, Kühn HJ, Wagner A, Kluge R, Hermann W. Differential alteration of the nigrostriatal dopaminergic system in Wilson’s disease investigated with [123I]ss-CIT and high-resolution SPET. Eur J Nucl Med. 2001;28:1656–63.PubMedCrossRef
Metadata
Title
Brain MRI, Tc-99m HMPAO SPECT and F-18 FP-CIT PET/CT Findings in a Patient with Wilson Disease: A Case Report
Authors
Seungyoo Kim
In Uk Song
Yong An Chung
Eun Kyung Choi
Jin Kyoung Oh
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 4/2014
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-014-0290-4

Other articles of this Issue 4/2014

Nuclear Medicine and Molecular Imaging 4/2014 Go to the issue